OrthoPediatrics Raises Full-Year Revenue Guidance Following Record Q3 Results
OrthoPediatrics (KIDS) reported record third-quarter revenue of $72.7 million, marking a 19% increase compared to the previous year. Driven by this strong performance, management has raised its full-year revenue guidance to a range of $270 million to $273 million, representing projected annual growth of 14% to 16%. Looking toward long-term financial stability, the company outlined an outlook for 2026 that targets revenue between $270 million and $273 million. Additionally, OrthoPediatrics is aiming to achieve $25 million in adjusted EBITDA and reach a free cash flow breakeven point or better by that period.
Tickers: $KIDS